DUNCAN MICHAEL R 4
4 · ATRIX LABORATORIES INC · Filed Oct 19, 2004
Insider Transaction Report
Form 4
DUNCAN MICHAEL R
VP and General Manager
Transactions
- Sale
Common Stock, $.001 Par Value
2004-10-18$30.14/sh−4,200$126,567→ 715 total - Exercise/Conversion
Common Stock, $.001 Par Value
2004-10-18$10.13/sh+4,200$42,525→ 4,915 total - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-10-18$10.13/sh−4,200$42,525→ 0 totalExercise: $10.13From: 1999-11-13Exp: 2008-11-13→ Common Stock (4,200 underlying) - Exercise/Conversion
Stock Option (Right-To-Buy)
2004-10-18$9.75/sh−800$7,800→ 19,200 totalExercise: $9.75From: 2000-11-15Exp: 2009-11-15→ Common Stock (800 underlying) - Exercise/Conversion
Common Stock, $.001 Par Value
2004-10-18$9.75/sh+800$7,800→ 1,515 total - Sale
Common Stock, $.001 Par Value
2004-10-18$30.14/sh−800$24,108→ 715 total
Footnotes (1)
- [F1]The stock option exercise and sale reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.